COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo® Product Compared to Epiduo® in the Treatment of Acne Vulgaris (Narciso)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02716090
Recruitment Status : Withdrawn (Due to budget limitations, the company decided to withdraw this study.)
First Posted : March 23, 2016
Last Update Posted : February 15, 2017
Information provided by (Responsible Party):
Ache Laboratorios Farmaceuticos S.A.

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : November 2015
Study Completion Date : No date given